Company Analysis

Nutriband Inc. (NTRB)

Nasdaq: NTRB · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Orlando, FL · filing with the SEC since 2016
Grade4.5
◀ Past 5.0● Present 4.6▶ Future 3.8
2 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

3 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Nutriband Inc.’s names, not what it holds today.

Patents granted
3
3 utility, 1976 to Dec 31, 2025
Granted in 2025
1
Against none in 2024 and 1 in 2023
Applications published
4
1 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'20'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals3
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Nutriband, Inc. its own name
named as the applicant on its applications, in US
0 granted
4 published
NUTRIBAND, INC. its own name
US, as the owner printed on each patent
3 granted
0 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Jun 3, 202512,318,492Abuse and misuse deterrent transdermal systemsPharmaceuticalsNUTRIBAND, INC.
Sep 19, 202311,759,431Abuse and misuse deterrent transdermal systemsPharmaceuticalsNUTRIBAND, INC.
Feb 15, 202211,246,840Abuse and misuse deterrent transdermal systemsPharmaceuticalsNUTRIBAND, INC.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Sep 18, 20252025/0288538ABUSE AND MISUSE DETERRENT TRANSDERMAL SYSTEMSPharmaceuticalsNutriband, Inc.
Jan 4, 20242024/0000720ABUSE AND MISUSE DETERRENT TRANSDERMAL SYSTEMSPharmaceuticalsNutriband, Inc. · patent 12,318,492 granted from it
Apr 28, 20222022/0125739Abuse and Misuse Deterrent Transdermal SystemsPharmaceuticalsNutriband, Inc. · patent 11,759,431 granted from it
Apr 16, 20202020/0113845Abuse and Misuse Deterrent Transdermal SystemsPharmaceuticalsNutriband, Inc. · patent 11,246,840 granted from it
What it applied for, 2024 to 2025: Pharmaceuticals 2.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton NTRB · research, not advice